Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
5%
Acute Lymphoblastic Leukemia
100%
Acute Myeloid Leukemia
17%
Advanced Stage
5%
Antiproliferative Effect
5%
Ara-C
9%
B Cells
6%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
7%
Bone Marrow
5%
Cell Lymphoma
5%
Chemotherapy
11%
Childhood Acute Lymphoblastic Leukemia
53%
Childhood Leukemia
8%
Children's Oncology Group
16%
Clinical Trials
11%
Clinical Utility
5%
Colon Cancer
5%
Colorectal Cancer
12%
Combination Chemotherapy
7%
Complete Remission
17%
Cranial Irradiation
5%
Curcumin
7%
Cytosine Arabinoside
7%
Egypt
5%
Etoposide
8%
Event-free Survival
11%
Ewing Sarcoma
5%
Flow Cytometry
6%
Gastrointestinal Cancer
7%
Group Studies
17%
Health Disparities
5%
Hepatocellular Carcinoma
5%
High Risk
22%
High-dose Methotrexate (HD-MTX)
8%
Immunogenicity
5%
Improved Outcomes
8%
In Cancer
6%
L-asparaginase
14%
Leukemia
12%
Leukemia Patients
7%
Liver Cancer
5%
Marrow
10%
Methotrexate
19%
Minimal Residual Disease
25%
Obesity
5%
Overall Survival
5%
Pancreatic Cancer
14%
Pancreatic Cancer Cells
8%
Pediatric
9%
Pediatric Acute Lymphoblastic Leukemia
5%
Pediatric Oncology
15%
Poultry
5%
Precursor B-cell Acute Lymphoblastic Leukemia
10%
Prednisone
10%
Prognostic Factors
6%
Relapse Risk
9%
Remission
10%
Remission Induction
9%
Risk Factors
7%
Sarcoma Cells
5%
Secondary Acute Myeloid Leukemia (sAML)
5%
Small Molecules
6%
Specificity Protein 1
11%
Standard Risk
6%
Survival Rate
5%
Survivin
8%
T Cells
7%
Texas
10%
Tolfenamic Acid
25%
Total Therapy
6%
Transcription Factor
6%
Tumor
7%
Tumorigenesis
5%
Type 2 Diabetes Mellitus (T2DM)
7%
United States
9%
VP16
6%
Working Diagnosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
5%
Acute Lymphoblastic Leukemia
42%
Acute Myeloid Leukemia
6%
Asparaginase
5%
Cancer Growth
5%
Carcinogenesis
7%
Chemotherapy Regimens
16%
Childhood Cancer
6%
Clinical Trial
13%
Colon Carcinoma
7%
Colorectal Carcinoma
10%
Curcumin
7%
Cytarabine
11%
Diseases
8%
Etoposide
9%
Immunotherapy
9%
Infection
5%
Intrathecal
6%
Leukemia
15%
Lymphatic Leukemia
6%
Malignant Neoplasm
27%
Methotrexate
23%
Minimal Residual Disease
5%
Nanoparticle
6%
Pancreas Cancer
17%
Prednisone
7%
Remission
16%
Teniposide
6%
Tolfenamic Acid
23%
Vincristine
10%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
67%
Acute Myeloid Leukemia
14%
Adolescence
9%
Asparaginase
5%
Cancer
6%
Chemotherapy
11%
Childhood Cancer
12%
Clinical Trial
8%
Cytarabine
13%
Diseases
8%
Etoposide
7%
Event Free Survival
8%
Immunotherapy
9%
Infection
5%
Leukemia
14%
Leukemia in Children
5%
Leukocyte
5%
Lymphoid Leukemia
5%
Malignant Neoplasm
8%
Maturity Onset Diabetes of the Young
5%
Methotrexate
17%
Minimal Residual Disease
23%
Oncology
12%
Pancreas Cancer
10%
Pediatrics
8%
Precursor
6%
Prednisone
7%
Spontaneous Remission
8%
Survival Rate
5%
Undifferentiated Lymphoma
5%
Vincristine
7%